ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

INAB IN8bio Inc

0,9902
-0,0198 (-1,96%)
11 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
IN8bio Inc INAB NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,0198 -1,96% 0,9902 01:00:11
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
1,00 0,9837 1,0199 0,9902 1,01
mais cotações »

Notícias Recentes

Data Hora Fonte Título
09/05/202417:00GLOBEIN8bio Reports First Quarter 2024 Financial Results and..
30/04/202407:05GLOBEIN8bio Doses First Patient in Phase 2 Clinical Trial of..
24/04/202409:00GLOBEIN8bio Announces Oral Presentation at the Upcoming American..
16/04/202417:05GLOBEIN8bio to Present at Noble Capital Markets Emerging Growth..
09/04/202417:30GLOBEIN8bio Announces New Preclinical Data for Gamma-Delta..
14/03/202417:00GLOBEIN8bio Reports Fourth Quarter and Full-Year 2023 Financial..
05/03/202418:30GLOBEIN8bio to Present New Preclinical Data on Novel Gamma-Delta..
26/02/202410:00BWIN8bio to Present at Upcoming Investor Conferences
14/02/202410:00GLOBEIN8bio Announces Publication on Novel Gamma-Delta T Cell..
04/01/202410:00GLOBEIN8bio Highlights Recent Company Accomplishments and..
11/12/202318:05GLOBEIN8bio Announces Positive Clinical Update Demonstrating..
11/12/202311:00GLOBEIN8bio Announces Pricing of Financing Totaling up to $46.9..
07/12/202310:00GLOBEIN8bio Appoints Dr. Corinne Epperly to Board of Directors
05/12/202310:00GLOBEIN8bio to Host Investor Call at 8:30 AM ET on Tuesday,..
20/11/202309:00GLOBEIN8bio’s INB-200 Demonstrates Extended Progression-Free..
10/11/202309:00GLOBEIN8bio to Present Data Highlighting Potential of INB-200 and..
09/11/202318:00GLOBEIN8bio Reports Third Quarter 2023 Financial Results and..
06/11/202310:00GLOBEIN8bio Presents Biologic Correlative Data from the INB-200..
03/11/202313:00GLOBEIN8bio Presents Positive Data Update from Induced..
02/11/202310:17GLOBEIN8bio to Present New Positive Data from Phase 1 Trial of..
01/11/202309:00GLOBEIN8bio to Participate at the 2023 Truist Securities..
12/10/202309:00GLOBEIN8bio Completes Dose Escalation in Phase 1 Trial of..
29/09/202309:00GLOBEIN8bio Announces Presentations at the Society for Immunology..
26/09/202309:00GLOBEIN8bio to Host Research & Development Day on its Gamma-Delta..
20/09/202309:00GLOBEIN8bio to Participate at the 2023 Cantor Fitzgerald Global..
19/09/202309:03GLOBEIN8bio Strengthens Intellectual Property Portfolio with..
06/09/202309:00GLOBEIN8bio to Participate at the H.C. Wainwright 25th Annual..
15/08/202309:00GLOBEIN8bio to Present at the H.C. Wainwright Immune Cell Engager..
10/08/202317:15GLOBEIN8bio Reports Second Quarter 2023 Financial Results and..
08/08/202309:00GLOBEIN8bio Expands Capabilities with the Grand Opening of its..
05/06/202309:00GLOBEIN8bio Announces Positive INB-200 Phase 1 Data Update in..
17/05/202309:00GLOBEIN8bio's DeltEx Gamma-Delta T Cells Show Promise in..

Seu Histórico Recente

Delayed Upgrade Clock